Cisen Overview

  • Year Founded
  • 1970

Year Founded

  • Status
  • Public

  • Employees
  • 3,000

Employees

  • Stock Symbol
  • 603367

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $1.90
  • (As of Wednesday Closing)

Cisen General Information

Description

Cisen Pharmaceutical Co Ltd is engaged in Research, development, production and sales of pharmaceutical products.

Contact Information

Formerly Known As
Shandong Lukang Chenxin Pharmaceutical
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Number 16 Tongji Road, High-tech Zone
  • Jining, Shandong 272073
  • China
+86 0537
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • Number 16 Tongji Road, High-tech Zone
  • Jining, Shandong 272073
  • China
+86 0537

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cisen Stock Performance

As of 18-Nov-2026, Cisen’s stock price is $1.90. Its current market cap is $859M with 453M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.90 $1.90 $1.78 - $2.89 $859M 453M 6.32M $0.12

Cisen Financials Summary

As of 30-Sep-2026, Cisen has a trailing 12-month revenue of $484M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 447,858 724,833 536,283 602,641
Revenue 484,029 479,010 554,887 630,731
EBITDA 61,352 92,622 106,734 112,333
Net Income 56,158 58,577 70,923 73,689
Total Assets 1,154,530 1,085,864 1,034,755 1,035,160
Total Debt 3,984 6,221 15,868 24,077
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cisen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cisen‘s full profile, request access.

Request a free trial

Cisen Patents

Cisen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023241507-A1 Crystal form of alkynylpyridine compound and preparation method therefor Inactive 13-Jun-2022
WO-2023088370-A1 Crystal form of fused-ring derivative and preparation method therefor Inactive 17-Nov-2021
EP-4265607-A1 Aminopyridine compound and application thereof Pending 15-Dec-2020
EP-4265607-A4 Aminopyridine compound and application thereof Pending 15-Dec-2020
US-12492169-B2 Aminopyridine compound and application thereof Active 15-Dec-2020 C07D213/73
To view Cisen’s complete patent history, request access »

Cisen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cisen Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cisen‘s full profile, request access.

Request a free trial

Cisen Investments (2)

Cisen’s most recent deal was a Secondary Transaction - Private with Guangzhou JOYO Pharma Company. The deal was made on 25-Apr-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Guangzhou JOYO Pharma Company 25-Apr-2018 Secondary Transaction - Private Pharmaceuticals
Joyo Pharma 27-Mar-2018 Secondary Transaction - Private Drug Discovery
To view Cisen’s complete investments history, request access »

Cisen ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Cisen’s complete esg history, request access »

Cisen FAQs

  • When was Cisen founded?

    Cisen was founded in 1970.

  • Where is Cisen headquartered?

    Cisen is headquartered in Jining, China.

  • What is the size of Cisen?

    Cisen has 3,000 total employees.

  • What industry is Cisen in?

    Cisen’s primary industry is Pharmaceuticals.

  • Is Cisen a private or public company?

    Cisen is a Public company.

  • What is Cisen’s stock symbol?

    The ticker symbol for Cisen is 603367.

  • What is the current stock price of Cisen?

    As of 18-Nov-2026 the stock price of Cisen is $1.90.

  • What is the current market cap of Cisen?

    The current market capitalization of Cisen is $859M.

  • What is Cisen’s current revenue?

    The trailing twelve month revenue for Cisen is $484M.

  • What is Cisen’s annual earnings per share (EPS)?

    Cisen’s EPS for 12 months was $0.12.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process